Opiant Pharmaceuticals has announced that their nasal spray, Narcan, which reverses opioid overdoses, will be sold for “less than $50” per kit. The announcement comes after the US government gave the company a $4.6 million contract to develop the spray. Although praised as a positive step in the fight against the opioid epidemic, critics say the price should be even lower, with a congressman urging the company to lower the price further. The Narcan spray is an important tool in the emergency treatment of opioid overdoses, blocking the effects of the drug and saving lives.
Nasal Spray for Opioid Overdoses to be Sold for “Less than $50”
The nasal spray that reverses opioid overdoses will sell for “less than $50” per kit, the manufacturer announced Thursday, spurring criticism that the price of the over-the-counter medication should be even lower. The announcement by Opiant Pharmaceuticals came after the US government awarded the company a $4.6m contract to develop the spray. The congressman who initiated the funding deal said the price was too high and demanded that the company lower it. The spray, called Narcan, is sprayed into the nose and blocks the effects of opioids, including drowsiness and slowed breathing.
Latest from Blog
Manu Chopra, CEO of Karya Inc., emphasized the importance of utilizing artificial intelligence (AI) to reduce
Italy has decided to withdraw from China's Belt and Road Initiative, becoming the only G7 nation
Zerodha's top executives collectively received a remuneration of about ₹200 crore in the financial year 2022-23,
New research suggests that radiotherapy may not be necessary for many patients with ductal carcinoma in
The US Space Force's X-37B space plane is gearing up for its seventh mission, after landing
